Stay updated on UB-221 Safety & Efficacy in CSU Patients Clinical Trial
Sign up to get notified when there's something new on the UB-221 Safety & Efficacy in CSU Patients Clinical Trial page.

Latest updates to the UB-221 Safety & Efficacy in CSU Patients Clinical Trial page
- CheckyesterdayChange DetectedThe page footer shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now shows Revision: v3.4.2 and removes older notices referencing government funding and a prior revision tag (v3.4.1); these updates appear to be maintenance-related and do not change the study details or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check44 days agoChange DetectedThe page now displays a site-wide notice about a lapse in government funding and the NIH operations status, and it shows a new revision tag (v3.4.1) replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check51 days agoChange DetectedThe page adds a glossary toggle and updates metadata labels, including 'Last Update Submitted that Met QC Criteria' and the revision string 'v3.4.0'. These changes are cosmetic and do not modify the study details, eligibility criteria, or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check65 days agoChange DetectedThe revision label on the page changed from v3.3.3 to v3.3.4. This appears to be a minor maintenance update that does not modify the study details or user interactions.SummaryDifference0.1%

Stay in the know with updates to UB-221 Safety & Efficacy in CSU Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UB-221 Safety & Efficacy in CSU Patients Clinical Trial page.